Skip to main content

Table 5 Quantitative analysis of tumor markers at baseline and third and sixth month after cell injection

From: Intrauterine infusion of clinically graded human umbilical cord-derived mesenchymal stem cells for the treatment of poor healing after uterine injury: a phase I clinical trial

 

Baseline

Third month

Sixth month

P value

CEA ng/ml

0.39 ± 0.34

0.49 ± 0.47

0.53 ± 0.43

 > 0.05

AFP ng/ml

2.97 ± 2.01

2.35 ± 1.12

3.44 ± 1.77

 > 0.05

CA 15–3 KU/L

2.34 ± 2.68

3.85 ± 3.43

6.93 ± 3.77

 > 0.05

CA-199 ng/ml

8.23 ± 6.58

6.45 ± 4.58

10.46 ± 5.49

 > 0.05

CA-125 U/ml

11.23 ± 7.6

12.75 ± 8.25

14.47 ± 9.63

 > 0.05

CA 72–4 U/ml

1.82 ± 2.48

2.24 ± 2.89

1 ± 1.52

 > 0.05

NSE ng/ml

2.25 ± 0.94

4.31 ± 2.86

6.43 ± 2.75

 > 0.05

Back to article page

Stem Cell Research & Therapy

ISSN: 1757-6512